AU2002340999A1 - Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use - Google Patents

Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use

Info

Publication number: AU2002340999A1
Authority: AU; Australia
Prior art keywords: phenylsulfonyl; indole; dihydro; derivatives; preparation
Prior art date: 2001-07-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002340999A

Other versions

AU2002340999B2 (en

Inventor

Alain Di Malta

Georges Garcia

Richard Roux

Bruno Schoentjes

Claudine Serradeil-Le Gal

Bernard Tonnerre

Jean Wagnon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Aventis France

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-17

Filing date

2002-07-15

Publication date

2003-05-22

2001-07-17 Priority claimed from FR0110359A external-priority patent/FR2827604B1/en

2002-07-15 Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France

2003-05-22 Publication of AU2002340999A1 publication Critical patent/AU2002340999A1/en

2005-02-17 Assigned to SANOFI-AVENTIS reassignment SANOFI-AVENTIS Amend patent request/document other than specification (104) Assignors: SANOFI-SYNTHELABO

2007-03-01 Application granted granted Critical

2007-03-01 Publication of AU2002340999B2 publication Critical patent/AU2002340999B2/en

2022-07-15 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002340999A 2001-07-17 2002-07-15 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use Ceased AU2002340999B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0110359A FR2827604B1 (en)	2001-07-17	2001-07-17	NOVEL 1-PHENYLSULFONYL-1,3-DIHYDRO-2H-INDOL-2- ONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR01/10359		2001-07-17
PCT/FR2002/002500 WO2003008407A2 (en)	2001-07-17	2002-07-15	Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use

Publications (2)

Publication Number	Publication Date
AU2002340999A1 true AU2002340999A1 (en)	2003-05-22
AU2002340999B2 AU2002340999B2 (en)	2007-03-01

Family

ID=8866211

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002340999A Ceased AU2002340999B2 (en)	2001-07-17	2002-07-15	Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use

Country Status (31)

Country	Link
US (1)	US7119086B2 (en)
EP (1)	EP1419150B1 (en)
JP (1)	JP4262088B2 (en)
KR (1)	KR20040017325A (en)
CN (1)	CN1224623C (en)
AR (1)	AR034792A1 (en)
AT (1)	ATE294171T1 (en)
AU (1)	AU2002340999B2 (en)
BR (1)	BR0211284A (en)
CA (1)	CA2450437A1 (en)
CO (1)	CO5550440A2 (en)
DE (1)	DE60203917T2 (en)
DK (1)	DK1419150T3 (en)
EA (1)	EA006019B1 (en)
ES (1)	ES2240814T3 (en)
FR (1)	FR2827604B1 (en)
HR (1)	HRP20040027A2 (en)
HU (1)	HUP0401461A3 (en)
IL (1)	IL159275A0 (en)
IS (1)	IS2485B (en)
MA (1)	MA27049A1 (en)
ME (1)	MEP24508A (en)
MX (1)	MXPA04000507A (en)
NO (1)	NO20040219L (en)
NZ (1)	NZ530144A (en)
PL (1)	PL366829A1 (en)
PT (1)	PT1419150E (en)
RS (1)	RS204A (en)
UA (1)	UA77181C2 (en)
WO (1)	WO2003008407A2 (en)
ZA (1)	ZA200309717B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7754711B2 (en) *	2003-07-30	2010-07-13	Xenon Pharmaceuticals Inc.	Pyridazine derivatives and their use as therapeutic agents
WO2005018531A2 (en) *	2003-08-26	2005-03-03	'chemical Diversity Research Institute', Ltd.	Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
RU2259999C2 (en) *	2003-08-26	2005-09-10	ООО "Исследовательский институт химического разнообразия"	1-sulfonyl-1,3-dihydroindole-2-ones, pharmaceutical compositions (variants), method for their preparing and applying
EP1659121A4 (en)	2003-08-28	2008-11-26	Taisho Pharmaceutical Co Ltd	D RIV OF 1,3-DIHYDRO-2H-INDOL-2-ONE
US8580842B2 (en) *	2003-09-30	2013-11-12	Abbott Gmbh & Co. Kg	Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US20050070718A1 (en) *	2003-09-30	2005-03-31	Abbott Gmbh & Co. Kg	Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US7514466B2 (en)	2004-04-27	2009-04-07	Wyeth	Purification of progesterone receptor modulators
DE102004033834A1 (en) *	2004-07-13	2006-02-02	Abbott Gmbh & Co. Kg	New 1-sulfonyl-2-oxo-dihydroindole derivatives are selective antagonists of vasopressin receptors useful e.g. for treating hypertension, cardiac insufficiency, unstable angina or affective disorders
EP1842555A4 (en) *	2004-12-27	2009-08-19	Univ Kyoto	TOLERANCE DEVELOPMENT INHIBITOR FOR A NARCOTIC ANALGESIC AGENT
WO2006080574A1 (en) *	2005-01-28	2006-08-03	Taisho Pharmaceutical Co., Ltd.	1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle
DE102005014936A1 (en) *	2005-03-24	2006-12-14	Abbott Gmbh & Co. Kg	New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
JP2008534461A (en)	2005-03-24	2008-08-28	アボットゲーエムベーハーウントカンパニーカーゲー	Substituted oxindole derivatives, medicaments containing said derivatives and uses thereof
DE102005014904A1 (en) *	2005-03-26	2007-02-01	Abbott Gmbh & Co. Kg	New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
US7576082B2 (en)	2005-06-24	2009-08-18	Hoffman-La Roche Inc.	Oxindole derivatives
SG132540A1 (en)	2005-11-25	2007-06-28	Matsushita Electric Industrial Co Ltd	Magnetic trap for ferrous contaminants in lubricant
JP2009517444A (en)	2005-12-02	2009-04-30	アボットゲーエムベーハーウントカンパニーカーゲー	Substituted oxindole derivatives, medicaments containing the same and uses thereof
CA2661870C (en) *	2006-08-26	2014-11-18	Abbott Gmbh & Co. Kg	Substituted benzimidazolone derivatives, medicaments comprising them and their use for treating vasopressin-dependent disease
DE102006040915A1 (en) *	2006-08-26	2008-03-20	Abbott Gmbh & Co. Kg	New oxindole derivatives useful for treating vasopressin- or oxytocin-dependent diseases
US20080167286A1 (en)	2006-12-12	2008-07-10	Abbott Laboratories	Pharmaceutical compositions and their methods of use
US8486979B2 (en) *	2006-12-12	2013-07-16	Abbvie Inc.	1,2,4 oxadiazole compounds and methods of use thereof
CL2007003878A1 (en) *	2006-12-30	2008-07-04	Basf Ag	COMPOUNDS DERIVED FROM 2-OXO-INDOL REPLACED, VASOPRESIN RECEPTOR MODULATORS; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PROFILAXIS OF DISEASES SUCH AS DIABETES, INSULIN RESISTANCE, INCONTIN
UY30846A1 (en) *	2006-12-30	2008-07-31	Abbott Gmbh & Amp	OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
WO2008107399A1 (en) *	2007-03-02	2008-09-12	Abbott Gmbh & Co. Kg	Substituted oxindole compounds
FR2920023B1 (en) *	2007-08-16	2013-02-08	Sanofi Aventis	3-DISUBSTITUTED INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
WO2009071691A2 (en) *	2007-12-07	2009-06-11	Abbott Gmbh & Co. Kg	Oxindole derivatives and the use thereof as a medication
MX2010006204A (en) *	2007-12-07	2011-03-16	Abbott Gmbh & Co Kg	5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases.
ES2397125T3 (en) *	2007-12-07	2013-03-04	Abbott Gmbh & Co. Kg	Oxindole derivatives substituted with halogen in position 5 and its use for the production of a medicine for the treatment of vasopressin-dependent diseases
US8703775B2 (en)	2007-12-07	2014-04-22	AbbVie Deutschland GmbH & Co. KG	Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
US8703774B2 (en) *	2007-12-07	2014-04-22	AbbVie Deutschland GmbH & Co. KG	Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
AU2008342569B2 (en)	2007-12-27	2014-01-16	AbbVie Deutschland GmbH & Co. KG	Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
FR2927625B1 (en) *	2008-02-19	2010-03-12	Sanofi Aventis	NOVEL 3-AMINOALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2930249B1 (en) *	2008-04-21	2010-05-14	Sanofi Aventis	NOVEL 3-AMINOALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
WO2010017827A1 (en) *	2008-08-14	2010-02-18	European Molecular Biology Laboratory	6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases
EP3677275B1 (en)	2008-10-17	2024-06-12	Sanofi-Aventis Deutschland GmbH	Combination of an insulin and a glp-1 agonist
FR2941947B1 (en) *	2009-02-12	2011-03-25	Sanofi Aventis	3-BENZOFURANYL-INDOL-2-ONE 3-DERIVED DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2941946B1 (en)	2009-02-12	2011-03-25	Sanofi Aventis	SUBSTITUTED 3-BENZOFURANYL-INDOL-2-ONE-3-ACETAMIDOPIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
US9040568B2 (en)	2009-05-29	2015-05-26	Abbvie Inc.	Pharmaceutical compositions for the treatment of pain
CA2763931A1 (en) *	2009-06-10	2010-12-16	Abbott Gmbh & Co. Kg	Use of substituted oxindole derivatives for the treatment and prophylaxis of pain
PL2498802T3 (en)	2009-11-13	2015-06-30	Sanofi Aventis Deutschland	Pharmaceutical composition comprising a glp-1 agonist, an insulin, and methionine
ES2965209T3 (en)	2009-11-13	2024-04-11	Sanofi Aventis Deutschland	Pharmaceutical composition comprising desPro36exendin-4(1-39)-Lys6-NH2 and methionine
US8088815B2 (en)	2009-12-02	2012-01-03	Hoffman-La Roche Inc.	Spiroindolinone pyrrolidines
US8288431B2 (en)	2010-02-17	2012-10-16	Hoffmann-La Roche Inc.	Substituted spiroindolinones
US8217044B2 (en)	2010-04-28	2012-07-10	Hoffmann-La Roche Inc.	Spiroindolinone pyrrolidines
AU2011202239C1 (en) *	2010-05-19	2017-03-16	Sanofi	Long-acting formulations of insulins
JP6199186B2 (en)	2010-08-30	2017-09-20	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
TWI527807B (en)	2010-12-21	2016-04-01	拜耳智慧財產有限公司	Method for preparing N-sulfonyl substituted anthrone
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI608847B (en)	2011-08-29	2017-12-21	賽諾菲阿凡提斯德意志有限公司	Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
AR087744A1 (en)	2011-09-01	2014-04-16	Sanofi Aventis Deutschland	PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
ES2709339T3 (en)	2013-04-03	2019-04-16	Sanofi Sa	Treatment of diabetes mellitus by formulations of long-acting insulins
ES2949095T3 (en)	2014-12-12	2023-09-25	Sanofi Aventis Deutschland	Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (en)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	Treatment type 2 diabetes mellitus patients
TW201705975A (en)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	Treatment of type 2 diabetes mellitus patients
EP3912625A1 (en) *	2020-05-20	2021-11-24	Kaerus Bioscience Limited	Novel maxi-k potassium channel openers for the treatment of fragile x associated disorders
KR20230090589A (en) *	2021-12-15	2023-06-22	국립해양생물자원관	Peptide derived from sea urchin and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2714378B1 (en) *	1993-12-24	1996-03-15	Sanofi Sa	Indol-2-one derivatives substituted in 3 with a nitrogen group, their preparation, pharmaceutical compositions containing them.
GB2326639A (en) *	1997-06-18	1998-12-30	Merck & Co Inc	Piperazine Oxytocin Receptor Antagonists
US20050070718A1 (en) *	2003-09-30	2005-03-31	Abbott Gmbh & Co. Kg	Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

2001
- 2001-07-17 FR FR0110359A patent/FR2827604B1/en not_active Expired - Fee Related
2002
- 2002-07-15 RS YU204A patent/RS204A/en unknown
- 2002-07-15 ME MEP-245/08A patent/MEP24508A/en unknown
- 2002-07-15 PL PL02366829A patent/PL366829A1/en not_active Application Discontinuation
- 2002-07-15 CN CNB028142624A patent/CN1224623C/en not_active Expired - Fee Related
- 2002-07-15 AT AT02774822T patent/ATE294171T1/en active
- 2002-07-15 ES ES02774822T patent/ES2240814T3/en not_active Expired - Lifetime
- 2002-07-15 EP EP02774822A patent/EP1419150B1/en not_active Expired - Lifetime
- 2002-07-15 HR HR20040027A patent/HRP20040027A2/en not_active Application Discontinuation
- 2002-07-15 HU HU0401461A patent/HUP0401461A3/en unknown
- 2002-07-15 WO PCT/FR2002/002500 patent/WO2003008407A2/en not_active Ceased
- 2002-07-15 PT PT02774822T patent/PT1419150E/en unknown
- 2002-07-15 BR BR0211284-1A patent/BR0211284A/en not_active IP Right Cessation
- 2002-07-15 KR KR10-2004-7000787A patent/KR20040017325A/en not_active Abandoned
- 2002-07-15 AU AU2002340999A patent/AU2002340999B2/en not_active Ceased
- 2002-07-15 EA EA200301306A patent/EA006019B1/en not_active IP Right Cessation
- 2002-07-15 MX MXPA04000507A patent/MXPA04000507A/en active IP Right Grant
- 2002-07-15 DK DK02774822T patent/DK1419150T3/en active
- 2002-07-15 IL IL15927502A patent/IL159275A0/en unknown
- 2002-07-15 JP JP2003513966A patent/JP4262088B2/en not_active Expired - Fee Related
- 2002-07-15 NZ NZ530144A patent/NZ530144A/en not_active IP Right Cessation
- 2002-07-15 US US10/484,370 patent/US7119086B2/en not_active Expired - Fee Related
- 2002-07-15 CA CA002450437A patent/CA2450437A1/en not_active Abandoned
- 2002-07-15 DE DE60203917T patent/DE60203917T2/en not_active Expired - Lifetime
- 2002-07-15 UA UA20031212069A patent/UA77181C2/en unknown
- 2002-07-16 AR ARP020102655A patent/AR034792A1/en unknown
2003
- 2003-12-15 IS IS7079A patent/IS2485B/en unknown
- 2003-12-15 ZA ZA200309717A patent/ZA200309717B/en unknown
2004
- 2004-01-09 MA MA27476A patent/MA27049A1/en unknown
- 2004-01-14 CO CO04002002A patent/CO5550440A2/en not_active Application Discontinuation
- 2004-01-16 NO NO20040219A patent/NO20040219L/en not_active Application Discontinuation

Publication	Publication Date	Title
AU2002340999A1 (en)	2003-05-22	Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HUP0401461A3 (en)	2009-06-29	Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2001282267A1 (en)	2002-02-18	Benzimidazole derivatives, preparation and therapeutic use thereof
AU2002359126A1 (en)	2003-06-30	Benzodiazepine derivatives, preparation thereof and use thereof
AU2922600A (en)	2000-09-28	Pyridopyranoazepine derivatives, preparation and therapeutic use
AU2002359123A1 (en)	2003-06-30	Benzodiazepine derivatives, preparation thereof and use thereof
AU2003255645A1 (en)	2003-12-22	Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
TWI318974B (en)	2010-01-01	Acylaminothiazole derivatives, their preparation and their therapeutic use
AU2001264042A1 (en)	2001-12-11	1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU2003269018A1 (en)	2004-02-09	Acylaminothiazole derivatives, preparation and therapeutic use thereof
TWI320413B (en)	2010-02-11	1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
AU2002233407A1 (en)	2003-02-06	2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2003260566A1 (en)	2003-12-12	Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
AU6846500A (en)	2001-02-19	Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU2002229870A1 (en)	2003-02-06	Mikanolide derivatives, their preparation and therapeutic uses
PL375309A1 (en)	2005-11-28	Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
AU2001284084A1 (en)	2002-01-30	Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
PL365342A1 (en)	2004-12-27	Mikanolide derivatives, their preparation and therapeutic uses
AU2001237518A1 (en)	2001-09-12	Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU2002308105A1 (en)	2003-04-10	Benzoaxathiepin derivatives and their use as medicines
IL161859A0 (en)	2005-11-20	3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
AU2002355351A1 (en)	2003-02-24	Acylaminothiazole derivatives, their preparation and therapeutic use
AU2001237517A1 (en)	2001-09-12	Haloimidazole derivatives, their preparation and therapeutic use
IL149653A0 (en)	2002-11-10	2-arylquinoline derivatives, preparation and therapeutic use thereof
IL156593A0 (en)	2004-01-04	Mikanolide derivatives, their preparation and therapeutic uses